Focus Partners Wealth
CHRS icon

Focus Partners Wealth’s Coherus Oncology CHRS Stock Holding History

Focus Partners Wealth’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9K Buy
13,495
+658
+5% +$1.07K ﹤0.01% 2734
2026
Q1 		$21.7K Buy
+12,837
New +$22.8K ﹤0.01% 2609
2025
Q4 		– Sell
-42,986
Closed -$135K – 2681
2025
Q3 		$135K Buy
+42,986
New +$47.8K ﹤0.01% 2103
2025
Q2 		– Sell
-10,857
Closed -$8.76K – 2053
2025
Q1 		$8.76K Buy
+10,857
New +$12.5K ﹤0.01% 1889

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Kohlberg Kravis Roberts & Co
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Focus Partners Wealth's CHRS Position: Q2 2026 in Review

Focus Partners Wealth increased its Coherus Oncology (CHRS) stake by 5.1% in Q2 2026, buying an estimated $1.07K and bringing the position to 13,495 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2734.

Focus Partners Wealth first reported a position in CHRS in Q1 2025 and has held it in 4 quarters since. The position peaked at $135K in Q3 2025. 146 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Focus Partners Wealth held 13,495 shares of Coherus Oncology worth $18.9K as of Q2 2026.
  • Focus Partners Wealth bought 658 Coherus Oncology shares in Q2 2026, an estimated $1.07K.
  • Coherus Oncology made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2734 holding.
  • Focus Partners Wealth first reported a position in Coherus Oncology in Q1 2025 and has held it in 4 quarters since.
  • Focus Partners Wealth's Coherus Oncology position peaked at $135K in Q3 2025.
  • 146 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.